Officials say two Coronavirus patients in New York City are off ventilators and out of intensive care after the received an experimental drug to treat HIV and breast cancer.

Doctors are steadily trying to find out which drug on the market or in development might help fight the Coronavirus.

The drug, leronlimab, is delivered by injection twice in the abdomen, the Daily Mail reported.

Seven critically ill patients received the drug but only two were removed from ventilations showing significant improvement.

Doctors right now don’t know quite how leronlimab works, but studies suggest it calms the overly aggressive immune response — known as a cytokine storm — that frequently leads to lung inflammation, pneumonia and potentially death.

CytoDyn, the drug’s manufacturer, could get FDA approval in six weeks if leronlimab continues to show promise.